These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10498208)

  • 21. Novel iodinated carboranes: synthesis of the 8-iodo-7,9-dicarba-nido-undecaborate anion and 2-iodo-1,7-dicarba-closo-dodecaborane.
    Safronov AV; Kabytaev KZ; Jalisatgi SS; Hawthorne MF
    Dalton Trans; 2014 Sep; 43(33):12467-9. PubMed ID: 24782077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carborane-based carbonic anhydrase inhibitors: insight into CAII/CAIX specificity from a high-resolution crystal structure, modeling, and quantum chemical calculations.
    Mader P; Pecina A; Cígler P; Lepšík M; Šícha V; Hobza P; Grüner B; Fanfrlík J; Brynda J; Řezáčová P
    Biomed Res Int; 2014; 2014():389869. PubMed ID: 25309911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disulfuration and hydrosulfuration of an alkyne at a 1,2-dicarba-closo-dodecaborane-thiolate ligand.
    Ye H; Xu B; Xie M; Li Y; Yan H
    Dalton Trans; 2011 Jun; 40(24):6541-6. PubMed ID: 21584338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insight into lipophilicity of deoxyribonucleoside‑boron cluster conjugates.
    Dąbrowska A; Matuszewski M; Zwoliński K; Ignaczak A; Olejniczak AB
    Eur J Pharm Sci; 2018 Jan; 111():226-237. PubMed ID: 28986193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure, docking study and structure-activity relationship of carborane-containing androgen receptor antagonist 3-(12-hydroxymethyl-1,12-dicarba-closo-dodecaboran-1-yl)benzonitrile.
    Ohta K; Goto T; Fujii S; Kawahata M; Oda A; Ohta S; Yamaguchi K; Hirono S; Endo Y
    Bioorg Med Chem; 2011 Jun; 19(11):3540-8. PubMed ID: 21536446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Porphyrin-carborane organometallic assemblies based on 1, 2-dicarba-closo-dodecaborane (12) ligands.
    Wang JQ; Ren CX; Weng LH; Jin GX
    Chem Commun (Camb); 2006 Jan; (2):162-4. PubMed ID: 16372092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent androgen antagonists based on carborane as a hydrophobic core structure.
    Fujii S; Goto T; Ohta K; Hashimoto Y; Suzuki T; Ohta S; Endo Y
    J Med Chem; 2005 Jul; 48(14):4654-62. PubMed ID: 16000001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two isostructural carboranes: 3-phenyl-1,2-dicarba-closo-dodecaborane(12) and 1-phenyl-1,7-dicarba-closo-dodecaborane(12).
    Grintselev-Knyazev GV; Lyssenko KA; Antipin MY; Knyazev SP; Kirin VN; Chernyshev EA
    Acta Crystallogr C; 2001 Jul; 57(Pt 7):827-9. PubMed ID: 11443255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of p-carborane bisphenols and their derivatives: structure-activity relationship for estrogenic activity.
    Ogawa T; Ohta K; Iijima T; Suzuki T; Ohta S; Endo Y
    Bioorg Med Chem; 2009 Feb; 17(3):1109-17. PubMed ID: 19141368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-glucosidase inhibitors with a 4,5,6,7-tetrachlorophthalimide skeleton pendanted with a cycloalkyl or dicarba-closo-dodecaborane group.
    Sou S; Takahashi H; Yamasaki R; Kagechika H; Endo Y; Hashimoto Y
    Chem Pharm Bull (Tokyo); 2001 Jun; 49(6):791-3. PubMed ID: 11411542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent estrogenic agonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.
    Endo Y; Iijima T; Yamakoshi Y; Yamaguchi M; Fukasawa H; Shudo K
    J Med Chem; 1999 May; 42(9):1501-4. PubMed ID: 10229620
    [No Abstract]   [Full Text] [Related]  

  • 32. A ternary supramolecular system containing a boronated DNA-metallointercalator, β-cyclodextrin and the hexanucleotide d(GTCGAC)2.
    Ching HY; Buck DP; Bhadbhade M; Collins JG; Rendina LM
    Chem Commun (Camb); 2012 Jan; 48(6):880-2. PubMed ID: 22138665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of boron clusters for drug design. Hansch-fujita hydrophobic parameters pi of dicarba-closo-dodecaboranyl groups.
    Yamamoto K; Endo Y
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2389-92. PubMed ID: 11527738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-Activity study of retinoid agonists bearing substituted dicarba-closo-dodecaborane. Relation between retinoidal activity and conformation of two aromatic nuclei.
    Endo Y; Iijima T; Yaguchi K; Kawachi E; Inoue N; Kagechika H; Kubo A; Itai A
    Bioorg Med Chem Lett; 2001 May; 11(10):1307-11. PubMed ID: 11392543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Closomers of high boron content: synthesis, characterization, and potential application as unimolecular nanoparticle delivery vehicles for boron neutron capture therapy.
    Ma L; Hamdi J; Wong F; Hawthorne MF
    Inorg Chem; 2006 Jan; 45(1):278-85. PubMed ID: 16390066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Isoniazid-Carborane Hybrids Active in Vitro Against
    Różycka D; Korycka-Machała M; Żaczek A; Dziadek J; Gurda D; Orlicka-Płocka M; Wyszko E; Biniek-Antosiak K; Rypniewski W; Olejniczak AB
    Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33333865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of closo- and nido-biscarboranes with rigid unsaturated linkers as precursors to linear metallacarborane-based molecular rods.
    Safronov AV; Sevryugina YV; Pichaandi KR; Jalisatgi SS; Hawthorne MF
    Dalton Trans; 2014 Apr; 43(13):4969-77. PubMed ID: 24149980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and modeling study of (2S,5R,6R)- and (2S,5R,6S)-6-hydroxy- 8-(1-decynyl)-benzolactam-V8 as protein kinase C modulators.
    Wei ZL; Sakamuri S; Petukhov PA; George C; Lewin NE; Blumberg PM; Kozikowski AP
    Org Lett; 2002 Jun; 4(13):2169-72. PubMed ID: 12074659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of boron clusters for drug design. Relation between estrogen receptor binding affinity and hydrophobicity of phenols bearing various types of carboranyl groups.
    Endo Y; Yamamoto K; Kagechika H
    Bioorg Med Chem Lett; 2003 Nov; 13(22):4089-92. PubMed ID: 14592514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation.
    Genady AR
    Eur J Med Chem; 2009 Jan; 44(1):409-16. PubMed ID: 18407378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.